Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Raw Materials (2016 - 2022)

Biomerica's Raw Materials history spans 11 years, with the latest figure at $1.4 million for Q1 2022.

  • On a quarterly basis, Raw Materials fell 3.68% to $1.4 million in Q1 2022 year-over-year; TTM through Feb 2022 was $1.4 million, a 3.68% decrease, with the full-year FY2021 number at $1.6 million, down 3.18% from a year prior.
  • Raw Materials hit $1.4 million in Q1 2022 for Biomerica, down from $1.4 million in the prior quarter.
  • Over the last five years, Raw Materials for BMRA hit a ceiling of $2.2 million in Q3 2020 and a floor of $989000.0 in Q3 2018.
  • Historically, Raw Materials has averaged $1.4 million across 5 years, with a median of $1.3 million in 2019.
  • Biggest five-year swings in Raw Materials: soared 82.33% in 2020 and later crashed 32.72% in 2021.
  • Tracing BMRA's Raw Materials over 5 years: stood at $1.1 million in 2018, then grew by 12.89% to $1.2 million in 2019, then skyrocketed by 44.58% to $1.7 million in 2020, then fell by 18.99% to $1.4 million in 2021, then dropped by 3.95% to $1.4 million in 2022.
  • Business Quant data shows Raw Materials for BMRA at $1.4 million in Q1 2022, $1.4 million in Q4 2021, and $1.5 million in Q3 2021.